Review Article
Targeting Insulin and Insulin-Like Growth Factor Pathways in Epithelial Ovarian Cancer
Table 2
Tissue expression modulations of the insulin/IGF system in ovarian cancer.
| Insulin/IGF components | No. of patients | Modulation | Reference |
| Free IGF-I mRNA and protein | 215 EOC | | [43] | IGF-I, IGF-IR mRNA, and several genes downstream of the receptor | 64 EOC | | [44] | IGF-II mRNA | 109 EOC | | [45] | IGF-II mRNA | 215 EOC | | [46] | IGFBP3 protein | 128 clear cell carcinoma | | [47] | IGFBP-2 mRNA | 113 EOC | | [48] | IGFBP-3 protein | 147 EOC | | [50] | IGFBP-3 protein | 35 endometrioid carcinoma | | [51] |
|
|
EOC: epithelial ovarian cancer.
|